Showing results (1401-1410 of 1,447) with videos related to

Sort By:
Pageof 145
Archives of Neurology|June 14, 2006
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD studyMei Sun, Jeanne C Latourelle, G Frederick Wooten, et al.
Annals of Surgical Oncology|July 23, 2025
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 TrialMandeep Kaur, Katrina Dimitroff, Judy C Boughey, et al.
Nature Aging|May 20, 2025
Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer's diseaseGyujin Heo, Ying Xu, Erming Wang, et al.
Nature Genetics|May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's diseaseGanqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
Movement Disorders Clinical Practice|October 11, 2025
Segmental and Multifocal Isolated Dystonias: Similarities and DifferencesHyder A Jinnah, Vittorio Velucci, Daniele Belvisi, et al.
Neurology|October 13, 2020
Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition CohortAasef G Shaikh, Sinem Balta Beylergil, Laura Scorr, et al.
NPJ Breast Cancer|August 23, 2018
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response EndpointJudy C Boughey, Michael D Alvarado, Rachael B Lancaster, et al.
Infection Control and Hospital Epidemiology|June 2, 2021
Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings-ten Emerging Infections Program sites, April-November 2020Nora Chea, Taniece Eure, Austin R Penna, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
NPJ Breast Cancer|January 25, 2019
Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response EndpointJudy C Boughey, Michael D Alvarado, Rachael B Lancaster, et al.
Pageof 145